{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:06:53Z","timestamp":1777860413940,"version":"3.51.4"},"reference-count":72,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2015.00134","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T16:09:20Z","timestamp":1427213360000},"source":"Crossref","is-referenced-by-count":26,"title":["Beh\u00e7et\u2019s Disease: Do Natural Killer Cells Play a Significant Role?"],"prefix":"10.3389","volume":"6","author":[{"given":"Harry","family":"Petrushkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Samiul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles R.","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farida","family":"Fortune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham R.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet\u2019s disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Behcet\u2019s disease, the silk road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"key":"B3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Behcet\u2019s disease in Istanbul, Turkey","volume":"42","author":"Azizlerli","year":"2003","journal-title":"Int J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1399-0039.2011.01714.x","article-title":"Natural killer cell subsets in man and rodents","volume":"78","author":"Inngjerdingen","year":"2011","journal-title":"Tissue Antigens"},{"key":"B6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/ni1114","article-title":"Interplay of natural killer cells and their receptors with the adaptive immune response","volume":"5","author":"Raulet","year":"2004","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells: \u201cl\u2019union fait la force\u201d","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1073\/pnas.1012356108","article-title":"Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation","volume":"108","author":"De Maria","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1046\/j.1365-2370.1997.d01-117.x","article-title":"Function and specificity of human natural killer cell receptors","volume":"24","author":"Moretta","year":"1997","journal-title":"Eur J Immunogenet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1084\/jem.186.7.1129","article-title":"p46, a novel natural killer cell-specific surface molecule that mediates cell activation","volume":"186","author":"Sivori","year":"1997","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.imbio.2013.03.005","article-title":"Therapeutic potency of poly I:C in HSV-induced inflammation through up-regulation of IL-15 receptor alpha","volume":"218","author":"Choi","year":"2013","journal-title":"Immunobiology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","article-title":"Intraocular cytokine environment in active Behcet uveitis","volume":"142","author":"Ahn","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1365-3083.2006.01844.x","article-title":"Levels of IL-15 in serum and cerebrospinal fluid of patients with Behcet\u2019s disease","volume":"64","author":"Hamzaoui","year":"2006","journal-title":"Scand J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2008.07.009","article-title":"Serum cytokine profiles in Behcet\u2019s disease: is there a role for IL-15 in pathogenesis?","volume":"121","author":"Curnow","year":"2008","journal-title":"Immunol Lett"},{"key":"B16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/319675a0","article-title":"Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy","volume":"319","author":"Karre","year":"1986","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/349329a0","article-title":"Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice","volume":"349","author":"Bix","year":"1991","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0198-8859(98)00097-4","article-title":"Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I)","volume":"60","author":"Furukawa","year":"1999","journal-title":"Hum Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.immuni.2006.03.006","article-title":"How do natural killer cells find self to achieve tolerance?","volume":"24","author":"Yokoyama","year":"2006","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.smim.2006.03.003","article-title":"Missing self recognition and self tolerance of natural killer (NK) cells","volume":"18","author":"Raulet","year":"2006","journal-title":"Semin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.0712229105","article-title":"HLA alleles determine differences in human natural killer cell responsiveness and potency","volume":"105","author":"Kim","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","article-title":"Close association of HLA-Bw51 with Behcet\u2019s disease","volume":"100","author":"Ohno","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"B24","first-page":"S3","article-title":"Genome-wide association studies in Behcet\u2019s disease: expectations and promises","volume":"29","author":"Gul","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1084\/jem.181.3.1133","article-title":"The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor","volume":"181","author":"Gumperz","year":"1995","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.4049\/jimmunol.157.8.3350","article-title":"Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells","volume":"157","author":"Peruzzi","year":"1996","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1084\/jem.184.4.1585","article-title":"A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705","volume":"184","author":"Peruzzi","year":"1996","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4049\/jimmunol.0902332","article-title":"Variable NK cell receptors exemplified by human KIR3DL1\/S1","volume":"187","author":"Parham","year":"2011","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/sj.gene.6363863","article-title":"A weak association of HLA-B*2702 with Behcet\u2019s disease","volume":"3","author":"Gul","year":"2002","journal-title":"Genes Immun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1186\/ar4328","article-title":"HLA and non-HLA genes in Behcet\u2019s disease: a multicentric study in the Spanish population","volume":"15","author":"Montes-Cano","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.humimm.2006.08.294","article-title":"Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides","volume":"67","author":"Gebreselassie","year":"2006","journal-title":"Hum Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/ar2695","article-title":"Identification of novel genetic susceptibility loci for Behcet\u2019s disease using a genome-wide association study","volume":"11","author":"Fei","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet\u2019s disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet\u2019s disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Behcet\u2019s disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/art.21060","article-title":"Whole-genome screening for susceptibility genes in multicase families with Behcet\u2019s disease","volume":"52","author":"Karasneh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/0008-5472.CAN-05-2776","article-title":"Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance","volume":"66","author":"Hayashi","year":"2006","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ng.2551","article-title":"Identification of multiple independent susceptibility loci in the HLA region in Behcet\u2019s disease","volume":"45","author":"Hughes","year":"2013","journal-title":"Nat Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/35014520","article-title":"Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand","volume":"405","author":"Boyington","year":"2000","journal-title":"Nature"},{"key":"B40","first-page":"1921","article-title":"Association of MICA gene and HLA-B*5101 with Behcet\u2019s disease in Greece","volume":"40","author":"Yabuki","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1399-0039.2005.00465.x","article-title":"Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet\u2019s disease in Caucasian patients","volume":"66","author":"Hughes","year":"2005","journal-title":"Tissue Antigens"},{"key":"B42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-3083.2006.01780.x","article-title":"Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Behcet\u2019s disease","volume":"64","author":"Munoz-Saa","year":"2006","journal-title":"Scand J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10384-007-0473-y","article-title":"Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behcet\u2019s disease in Turkey","volume":"51","author":"Mizuki","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"113ra124","DOI":"10.1126\/scitranslmed.3002922","article-title":"An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation","volume":"3","author":"Shafi","year":"2011","journal-title":"Sci Transl Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/ar3005","article-title":"Natural killer cells control a T-helper 1 response in patients with Behcet\u2019s disease","volume":"12","author":"Yamaguchi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.1406575111","article-title":"Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity","volume":"111","author":"Ombrello","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2049-6958-8-29","article-title":"Pulmonary manifestations in Behcet disease: impaired natural killer cells activity","volume":"8","author":"Hamzaoui","year":"2013","journal-title":"Multidiscip Respir Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/rheumatology\/keh311","article-title":"Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet\u2019s disease","volume":"43","author":"Treusch","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.4049\/jimmunol.167.4.1877","article-title":"Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells","volume":"167","author":"Rajagopalan","year":"2001","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.4049\/jimmunol.168.12.6208","article-title":"KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential","volume":"168","author":"Faure","year":"2002","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.4049\/jimmunol.166.12.7260","article-title":"Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4","volume":"166","author":"Katz","year":"2001","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/rheumatology\/keh063","article-title":"Expression of KIR and C-type lectin receptors in Behcet\u2019s disease","volume":"43","author":"Saruhan-Direskeneli","year":"2004","journal-title":"Rheumatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1399-0039.2007.00929.x","article-title":"No association of KIR genes with Behcet\u2019s disease","volume":"70","author":"Middleton","year":"2007","journal-title":"Tissue Antigens"},{"key":"B55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/09273948.2012.754905","article-title":"Diversity of killer cell immunoglobulin-like receptor genes in uveitis associated with autoimmune diseases: ankylosing spondylitis and Behcet disease","volume":"21","author":"Moon","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"B56","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A","volume":"95","author":"Lee","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4049\/jimmunol.161.2.571","article-title":"Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition","volume":"161","author":"Winter","year":"1998","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1399-0039.2007.00907.x","article-title":"Association of CD94\/NKG2A, CD94\/NKG2C, and its ligand HLA-E polymorphisms with Behcet\u2019s disease","volume":"70","author":"Seo","year":"2007","journal-title":"Tissue Antigens"},{"key":"B59","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1084\/jem.187.5.813","article-title":"Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94\/NKG2 confers protection from natural killer cell-mediated lysis","volume":"187","author":"Borrego","year":"1998","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1399-0039.2006.00742.x","article-title":"HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet\u2019s disease","volume":"69","author":"Park","year":"2007","journal-title":"Tissue Antigens"},{"key":"B61","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00251-001-0392-x","article-title":"MICA genetic polymorphism and linkage disequilibrium with HLA-B in 29 African-American families","volume":"53","author":"Tian","year":"2001","journal-title":"Immunogenetics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.humimm.2006.02.009","article-title":"Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations","volume":"67","author":"Gao","year":"2006","journal-title":"Hum Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.humimm.2009.04.005","article-title":"MICA-HLA-B haplotype diversity and linkage disequilibrium in a population of Jewish descent from Majorca (the Balearic Islands)","volume":"70","author":"Cambra","year":"2009","journal-title":"Hum Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3346\/jkms.2002.17.3.366","article-title":"Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet\u2019s disease","volume":"17","author":"Park","year":"2002","journal-title":"J Korean Med Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s002510100325","article-title":"Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family","volume":"53","author":"Steinle","year":"2001","journal-title":"Immunogenetics"},{"key":"B66","first-page":"2193","article-title":"MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia","volume":"27","author":"Ricci-Vitiani","year":"2000","journal-title":"J Rheumatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0198-8859(01)00242-7","article-title":"Polymorphism in MICA rather than HLA-B\/C genes is associated with psoriatic arthritis in the Jewish population","volume":"62","author":"Gonzalez","year":"2001","journal-title":"Hum Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.humimm.2005.09.004","article-title":"Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism","volume":"66","author":"Amroun","year":"2005","journal-title":"Hum Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1073\/pnas.94.4.1298","article-title":"Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease","volume":"94","author":"Mizuki","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B70","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nature10517","article-title":"Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B","volume":"479","author":"Vivian","year":"2011","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00296-003-0352-x","article-title":"Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behcet\u2019s disease","volume":"24","author":"Takeno","year":"2004","journal-title":"Rheumatol Int"},{"key":"B72","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/gene.2013.55","article-title":"KIR3DL1 genetic diversity and phenotypic variation in the Chinese Han population","volume":"15","author":"Tao","year":"2014","journal-title":"Genes Immun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T23:53:18Z","timestamp":1691538798000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2015.00134\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":72,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2015.00134","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}